Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Pegvisomant

U.S. FDA Requirements: Pegvisomant

Pharmaceutical / Drug Definition : Selectively binds to GH receptors on cell surfaces, where it blocks binding of endogenous GH and interferes with GH signal transduction. This action decreases blood levels of insulin-like growth factor-1 (IGF-1) and other GH-responsive serum proteins.

Registrar Corp assists Pegvisomant companies with:

  • FDA Registration Pegvisomant
  • FDA Listing Pegvisomant
  • FDA Label Requirements and Exceptions Pegvisomant
  • FDA Import Information Pegvisomant
  • FDA Detentions Pegvisomant (Pegvisomant Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Pegvisomant (Pegvisomant Suppliers)
       - Processors Pegvisomant
       - Repackers Pegvisomant
       - Relabelers Pegvisomant
       - Exporters Pegvisomant
       - Importers Pegvisomant
For more information about Pegvisomant, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco